Skip to main content
. 2005 Aug 6;5:12. doi: 10.1186/1471-2490-5-12

Table 2.

Frequency distribution of NAT2 genotypes in prostate cancer patients and controls.

Patients NAT2 genotype P – value Unadjusted OR (95% CI) Adjusted OR
Slow – acetylators Rapid-acetylators
Controls (n = 140) 62 (44.29%) 78 (55.71%) 1.0 (Reference) 1.0
Prostate cancer (n = 130) 46 (35.38%) 84 (64.62%) 0.136 1.452 (0.54–1.87) 1.348 (0.39–2.28)

Adjusted OR = Age adjusted odds ratio.